Delivery Order SPE2DB22D3301-SPE2DB25FZ1DG
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Prevnar 20 vaccine syringes (0.5mL) with a contract ceiling value of $3,686.72. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award used no set-aside designation, indicating it was...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of PREVNAR 20 vaccine in syringe form (0.5mL). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,173.32 and is scheduled for completion by August 5, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This $10,328.81 firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by August 18, 2025. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Prevnar 20 syringe 0.5ml vaccine doses. This competitively awarded, firm fixed-price delivery order has a ceiling value of $30,228.59 and is scheduled for completion by May 5, 2025. The order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance taking place at the company's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This competitive, non-set-aside contract is valued at $16,984.67 and carries a completion date of September 3, 2025. The award will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes with a firm fixed price ceiling value of $13,530.93 and an ultimate completion date of October 24, 2025. This non-set-aside award was competitively procured and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order has a ceiling value of $4,901.31 and is scheduled for completion by September 10, 2025. The contract involves performance at AmerisourceBergen's Conshohocken, Pennsylvania location and carries no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $46,889.08 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This firm fixed price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency (DLA) for the supply of Prevnar 20 vaccines in 0.5mL syringes. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1DGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringes. This competitively awarded, firm fixed-price delivery order has a ceiling value of $464,186.60 and an ultimate completion date of September 18, 2025. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies vaccines, medications, and specialized healthcare commodities to military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems with critical pharmaceutical products. The award demonstrates AmerisourceBergen's established capability to deliver medical supplies through competitive procurement processes, consistent with its extensive portfolio of federal contract awards with the DLA and its strategic positioning within the Pharmaceutical Prime Vendor Global Program initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $464.2k | 9/17/25 |